A detailed history of Sagefield Capital LP transactions in Exscientia PLC stock. As of the latest transaction made, Sagefield Capital LP holds 125,125 shares of EXAI stock, worth $605,605. This represents 0.07% of its overall portfolio holdings.

Number of Shares
125,125
Holding current value
$605,605
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.26 - $6.0 $533,032 - $750,750
125,125 New
125,125 $610,000

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Sagefield Capital LP Portfolio

Follow Sagefield Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sagefield Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sagefield Capital LP with notifications on news.